Development Level

Tbio 20 | 11,445
Tchem 2 | 1,598

IMPC Phenotype

abnormal coat appearance 2 | 31
preweaning lethality, complete... 2 | 979
preweaning lethality, incomple... 2 | 499
abnormal eye morphology 1 | 68
decreased body weight 1 | 161
decreased circulating HDL chol... 1 | 68
decreased circulating LDL chol... 1 | 38
decreased circulating chloride... 1 | 30
decreased circulating choleste... 1 | 93
decreased circulating creatini... 1 | 39
decreased circulating glucose ... 1 | 126
decreased circulating glycerol... 1 | 16
decreased circulating sodium l... 1 | 22
decreased fasted circulating g... 1 | 65
decreased neutrophil cell numb... 1 | 42
decreased red blood cell distr... 1 | 41
decreased spleen weight 1 | 10
decreased urine creatinine lev... 1 | 3
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
increased B cell number 1 | 9
increased bone mineral content 1 | 108
increased bone mineral density 1 | 72
increased circulating alkaline... 1 | 122
increased circulating total pr... 1 | 28
increased fasted circulating g... 1 | 76
increased hemoglobin content 1 | 45
increased lymphocyte cell numb... 1 | 32
increased total body fat amoun... 1 | 134
long tibia 1 | 25

Disease

Carcinoma 15 | 11,493
ovarian cancer 14 | 8,520
glioblastoma 12 | 5,792
medulloblastoma, large-cell 11 | 6,241
osteosarcoma 11 | 7,950
atypical teratoid / rhabdoid tumor 10 | 5,112
psoriasis 10 | 6,694
invasive ductal carcinoma 8 | 2,951
intraductal papillary-mucinous carcinoma (IPMC) 7 | 2,989
Breast cancer 6 | 3,578
acute quadriplegic myopathy 6 | 1,158
adult high grade glioma 6 | 3,801
group 4 medulloblastoma 6 | 1,855
intraductal papillary-mucinous neoplasm (IPMN) 6 | 3,291
Astrocytoma, Pilocytic 5 | 3,081
ependymoma 5 | 4,679
non-small cell lung cancer 5 | 2,890
astrocytic glioma 4 | 2,597
dermatomyositis 4 | 966
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,955
lung cancer 4 | 4,740
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
pediatric high grade glioma 4 | 1,064
subependymal giant cell astrocytoma 4 | 2,287
Cancer 3 | 2,499
Duchenne muscular dystrophy 3 | 601
Intellectual disability 3 | 1,016
Multiple myeloma 3 | 1,332
breast carcinoma 3 | 1,638
ductal carcinoma in situ 3 | 1,745
lung adenocarcinoma 3 | 2,716
oligodendroglioma 3 | 2,850
primary pancreatic ductal adenocarcinoma 3 | 1,109
primitive neuroectodermal tumor 3 | 3,035
spina bifida 3 | 1,074
Amyotrophic lateral sclerosis 2 | 451
Autosomal recessive predisposition 2 | 1,442
Cataract 8 multiple types 2 | 33
Cognitive delay 2 | 608
Congenital Epicanthus 2 | 177
Dull intelligence 2 | 645
Global developmental delay 2 | 608
Hereditary Sensory Autonomic Neuropathy, Type 1 2 | 4
Kidney cancer 2 | 2,613
Low intelligence 2 | 645
Mental Retardation 2 | 645
Mental and motor retardation 2 | 608
Mental deficiency 2 | 645
Motor delay 2 | 147
Muscle Cramp 2 | 55
Neurodegenerative disease 2 | 414
Neuropathy 2 | 261
No development of motor milestones 2 | 147
Paraplegia 2 | 74
Pick disease 2 | 1,894
Poor school performance 2 | 645
Proximal muscle weakness 2 | 47
Proximal neurogenic muscle weakness 2 | 47
Rheumatoid arthritis 2 | 1,191
Upward slant of palpebral fissure 2 | 75
astrocytoma 2 | 1,146
colon cancer 2 | 1,478
diabetes mellitus 2 | 1,728
group 3 medulloblastoma 2 | 4,104
juvenile dermatomyositis 2 | 1,187
lung carcinoma 2 | 2,843
malignant mesothelioma 2 | 3,232
pancreatic cancer 2 | 2,398
pituitary cancer 2 | 1,972
progressive supranuclear palsy 2 | 676
Acro-Osteolysis 1 | 12
Adult T-cell leukemia 1 | 5
Bilateral ptosis 1 | 9
Blastic phase chronic myeloid leukemia 1 | 58
Blindness, Cortical 1 | 24
Bronchiolitis 1 | 18
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Cortical visual impairment 1 | 24
Curly hair (finding) 1 | 14
Decreased size of teeth 1 | 62
Decreased width of tooth 1 | 59
Enlarged thorax 1 | 18
Gastrointestinal stromal tumor 1 | 62
Infection of bone 1 | 19
MENTAL RETARDATION, AUTOSOMAL DOMINANT 34 1 | 1
Morphological abnormality of the pyramidal tract 1 | 12
Non-small cell lung cancer, positive for epidermal growth factor receptor expression 1 | 4
ODONTOID HYPOPLASIA 1 | 16
Pancreatic Neuroendocrine Tumor 1 | 45
Platyspondyly 1 | 56
Polycystic liver disease 1 | 16
Postnatal microcephaly 1 | 24
Pyramidal tract disease 1 | 12
Reflex sympathetic dystrophy 1 | 7
Simple syndactyly of toes, first web space 1 | 23
Spindle cell hemangioma 1 | 16
Static Tremor 1 | 21
Tonic - clonic seizures 1 | 44
Wide spaced nipples 1 | 46
Widely spaced teeth 1 | 31

Tissue

Blood and immune system 22 | 16,909
Cardiovascular System 22 | 15,192
Digestive Tract 22 | 17,369
Endocrine System 22 | 18,159
Female tissues 22 | 17,400
Liver and Pancreas 22 | 16,750
Male tissues 22 | 17,142
Nervous System 22 | 16,725
Respiratory system 22 | 16,393
Skin and soft tissues 22 | 17,230
Urinary Tract 22 | 16,678

Target Family

Non-IDG 19 | 12,091
Kinase 2 | 634
Enzyme 1 | 4,145

GO Process

endoplasmic reticulum organiza... 22 | 22
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Atlastin-1 ATL1 Tbio Non-IDG -2.07795 119.7 164
Protein dopey-2 DOPEY2 Tbio Non-IDG -0.68663 6.12 17
Protein transport protein Sec16A SEC16A Tbio Non-IDG -1.49890 33.9 31
Transmembrane and coiled-coil domains protein 1 TMCC1 Tbio Non-IDG -0.80286 5.64 62
Atlastin-2 ATL2 Tbio Non-IDG -1.20941 15.1 91
Caveolin-2 CAV2 Tbio Non-IDG -2.43448 254.2 294
Protein ERGIC-53 LMAN1 Tbio Non-IDG -2.44907 270.7 118
Eukaryotic translation initiation factor 2-alpha kinase 3 EIF2AK3 Tchem Kinase -3.05781 896.8 450
Coiled-coil domain-containing protein 47 CCDC47 Tbio Non-IDG -0.12494 1.33 127
Atlastin-3 ATL3 Tbio Non-IDG -0.92471 7.59 164